BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Ceapro Inc. (CV:CZO) Announces the Completion of a License and Distribution Agreement With Oat Cosmetics Ltd. for the Sale of Its All-Natural Active Ingredients in the United Kingdom


6/23/2010 9:01:29 AM

EDMONTON, ALBERTA--(Marketwire - June 23, 2010) - Ceapro Inc. (TSX VENTURE: CZO) is pleased to announce today the completion of a new marketing partnership and distribution agreement with UK firm, Oat Cosmetics Ltd. The agreement encompasses all of Ceapro's current range of all-natural active ingredients.

Oat Cosmetics is an ethical, customer-focused company supplying the market with 100% natural, traceable cosmetic ingredients. The company recently announced the global launch of its first products including Ceapro Oat avenanthramides. The company plans to extend its portfolio with the launch in a few months of other ingredients (including Ceapro Oat Beta Glucan as well as enhanced formulations of Ceapro Oat Peptides and Ceapro Sweet Blue Lupin Peptides).

Said Mr Cark Maunsell, Managing Director of Oat Cosmetics "We anticipate the combination of Ceapro's quality products and Oat Services strengths in marketing and formulation in the UK market will provide the foundation for a very successful long-term partnership."

Ceapro President and Acting CEO, Mr. Gilles Gagnon reaffirmed the Company's growth strategy of international market expansion. "We are very pleased to team up with Oat Cosmetics which has made a significant investment in marketing and formulation services in support of the launch. This is a step forward in implementing our new strategy of partnering with notable regional and market sector specialists. By positioning our new compounds in the $8 billion global market for all-natural cosmetics we fully expect to win over new customers to our products and expertise."

About Ceapro Inc.

Ceapro Inc. is a Canadian growth-stage biotechnology company. Primary business activities relate to the development and commercialization of natural products for personal care and cosmetic industries using proprietary technology and natural, renewable resources. The commercial line of natural active ingredients include beta glucan, avenanthamides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides.

To learn more about Ceapro, visit www.ceapro.com

The TSX Venture Exchange nor its Regulation Services Provide (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Contacts:
Ceapro Inc.
Branko Jankovic
Chief Financial Officer
Telephone (Edmonton): 780-917-8376
bjankovic@ceapro.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES